New Health Insurance Mandate Requires Coverage for 'Restorative Care' Following Gender Procedures Starting 2027

If your health insurance plan covers gender-affirming surgeries or hormone treatments, a new bill called the TRUTH in Coverage Act of 2026 wants to ensure the 'fine print' works both ways. Starting January 1, 2027, any insurance provider that pays for what the bill calls 'sex-rejecting procedures' must also foot the bill for 'restorative care' to treat any physical or psychological complications that follow. This isn't just about a quick follow-up visit; the bill mandates that insurance companies treat these restorative services with the same financial rules—like deductibles and copays—as any other standard medical or surgical procedure.

The Safety Net for Complications

The bill defines 'restorative care' with an incredibly wide lens, covering everything from surgical revisions and hormone imbalances to bone density issues and even speech therapy. For example, if someone had a procedure years ago and is now facing chronic pain, nerve damage, or cardiovascular issues linked to that treatment, their current insurance would have to cover the care even if they weren't the original insurer. This also includes mental health support for conditions like depression or 'identity distress' related to the procedures. For a worker at a small business or a freelancer buying their own plan, this could mean the difference between paying tens of thousands out-of-pocket for a corrective surgery or having it covered under their standard plan benefits.

Redefining the Terms

While the bill adds a layer of protection for those needing follow-up care, it does so by using very specific biological definitions. It defines 'sex' strictly as male or female based on genetics at fertilization (Sec. 2). This language is a significant shift from how many modern medical organizations view gender identity. By labeling gender-affirming care as 'sex-rejecting procedures,' the bill creates a new legal category for these medical services. This could lead to a tug-of-war between doctors and insurance companies over how certain treatments are classified, potentially complicating how you or your family members access care if the definitions in the bill don't align with your medical provider’s diagnosis.

The Cost of the 'Fine Print'

For the busy professional or the employer managing a team's benefits, the biggest ripple effect might be the bottom line. Because the bill requires coverage for a massive list of potential complications—including long-term cancer screenings and fertility assessments (Sec. 2)—insurance companies are likely to see their costs go up. When insurers face higher payouts, those costs often trickle down to you in the form of higher monthly premiums or more rigorous 'prior authorization' hurdles. While the bill seeks to prevent unfair treatment limits, the sheer volume of mandated 'restorative' services means your HR department might be looking at more expensive plan options come 2027.